D-Gen

D-Gen

Owns technology for use in applications in this field including diagnostic tests and potential therapeutics.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20092020
Revenues<1m<1m
EBITDA(<1m)-
% EBITDA margin(89 %)-
Profit(<1m)-
% profit margin(159 %)-
  • Edit
DateInvestorsAmountRound

N/A

Spinout
Total Funding-

Recent News about D-Gen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.